BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu Y, Wei L, Wang H. Progress and perspectives on nanoplatforms for drug delivery to the brain. Journal of Drug Delivery Science and Technology 2020;57:101636. [DOI: 10.1016/j.jddst.2020.101636] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Aminu N, Bello I, Umar NM, Tanko N, Aminu A, Audu MM. The influence of nanoparticulate drug delivery systems in drug therapy. Journal of Drug Delivery Science and Technology 2020;60:101961. [DOI: 10.1016/j.jddst.2020.101961] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Emad NA, Ahmed B, Alhalmi A, Alzobaidi N, Al-kubati SS. Recent progress in nanocarriers for direct nose to brain drug delivery. Journal of Drug Delivery Science and Technology 2021;64:102642. [DOI: 10.1016/j.jddst.2021.102642] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Tripathi S, Gupta U, Ujjwal RR, Yadav AK. Nano-lipidic formulation and therapeutic strategies for Alzheimer's disease via intranasal route. J Microencapsul 2021;38:572-93. [PMID: 34591731 DOI: 10.1080/02652048.2021.1986585] [Reference Citation Analysis]
4 Javed S, Mangla B, Almoshari Y, Sultan MH, Ahsan W. Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnology Reviews 2021;11:1744-77. [DOI: 10.1515/ntrev-2022-0109] [Reference Citation Analysis]